FDA approves DUCORD product for stem cell transplants
Duke University School of Medicine has received approval from the Food and Drug Administration to market DUCORD, a stem cell product derived from umbilical cord blood, for use in transplants between unrelated donors and recipients.
Medical research
Oct 09, 2012 |
not rated yet |
0
BMI and lean body mass decline after allogeneic HSCT
(HealthDay)—In survivors of childhood hematologic malignancies who have received allogeneic hematopoietic stem cell transplantation (alloHSCT), body mass index (BMI) decreases significantly, mainly due ...
Cancer
Oct 04, 2012 |
2 / 5 (1) |
0
Study suggests stem cell transplant survivors at increased risk of developing heart disease
New research appearing online today in Blood, the journal of the American Society of Hematology (ASH), suggests that long-term survivors of hematopoietic cell transplants (HCT) are at an increased risk of developing hear ...
Cardiology
Oct 03, 2012 |
not rated yet |
0
|
Researchers harness the immune system to improve stem cell transplant outcomes
A novel therapy in the early stages of development at Virginia Commonwealth University Massey Cancer Center shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant ...
Immunology
Oct 01, 2012 |
5 / 5 (1) |
0
|
Therapeutic time window important factor for cord blood cell transplantation after stoke
A research team from Germany has found that optimal benefit and functional improvement for ischemic stroke results when human umbilical cord blood mononuclear cells (hUCB MNCs) are transplanted into rat stroke models within ...
Medical research
Oct 01, 2012 |
not rated yet |
0
Deadly complication of stem cell transplants reduced in mice
(Medical Xpress)—Studying leukemia in mice, researchers at Washington University School of Medicine in St. Louis have reduced a life-threatening complication of stem cell transplants, the only curative treatment when leukemia ...
Medical research
Sep 27, 2012 |
5 / 5 (1) |
0
|
Therapeutic impact of cell transplantation aided by magnetic factor
Two studies in the current issue of Cell Transplantation (21:6), now freely available on-line, demonstrate how the use of magnetic particles are a factor that can positively impact on the targeted delivery of transplante ...
Medical research
Sep 24, 2012 |
5 / 5 (1) |
0
'Berlin Man,' doctor convinced HIV cure is real
(AP)—More than five years after a radical treatment, a San Francisco man and his German doctor are convinced that he remains the first person cured of infection with HIV, the virus that causes AIDS.
HIV & AIDS
Sep 12, 2012 |
5 / 5 (1) |
0
New genetic clues to why most bone marrow transplant patients develop graft-versus-host disease
A team of scientists led by a bone marrow transplant researcher at Fred Hutchinson Cancer Research Center has shed new light on why most bone marrow transplant patients who receive tissue-matched cells from unrelated donors ...
Medical research
Sep 04, 2012 |
4 / 5 (1) |
0
|
Particular donor genotype lowers leukemia relapse rate
(HealthDay)—Patients with acute myeloid leukemia who receive a stem cell transplant from a donor with activating killer-cell immunoglobulin-like receptor (KIR) genotype KIR2DS1, which has ligand specif ...
Cancer
Aug 30, 2012 |
not rated yet |
0
B cell survival holds key to chronic graft vs. host disease
Leukemia and lymphoma patients who receive life-saving stem cell or bone marrow transplants often experience chronic side effects that significantly decrease quality of life, can last a lifetime, and ultimately affect their ...
Diseases, Conditions, Syndromes
Aug 16, 2012 |
not rated yet |
0
|
Stem cells may prevent post-injury arthritis
Duke researchers may have found a promising stem cell therapy for preventing osteoarthritis after a joint injury.
Arthritis & Rheumatism
Aug 10, 2012 |
5 / 5 (1) |
0
|
Bortezomib beneficial in graft-versus-host disease prophylaxis
(HealthDay) -- Patients with hematologic malignancies undergoing an HLA-mismatched unrelated donor (MMUD) reduced-intensity conditioning (RIC) hematopoietic stem cell transplantation (HSCT) may benefit from ...
Cancer
Aug 08, 2012 |
not rated yet |
0
Small breakthroughs offer big hope of AIDS 'cure'
Small but significant breakthrough studies on people who have been able to overcome or control HIV were presented Thursday at a major world conference on ways to stem the three-decade-old disease.
HIV & AIDS
Jul 26, 2012 |
not rated yet |
0
Bone marrow transplant eliminates signs of HIV infection
Two men with longstanding HIV infections no longer have detectable HIV in their blood cells following bone marrow transplants. The virus was easily detected in blood lymphocytes of both men prior to their transplants but ...
HIV & AIDS
Jul 26, 2012 |
not rated yet |
0
